For patients reading about retatrutide weight loss research, the key point is that the drugs impact appears to extend beyond just a simple scale change
The medication supports regrowth but doesnt directly stop GLP-1related shedding
FDA Warning: RISK FOR ILEUS (INTESTINAL BLOCKAGE) (FDA 09/22/2023) Amongst more than 8,500 voluntary reports of GI disorders associated with the use of semaglutide reported through June 30, 2023, ileus was included in 33 cases, and two cases of death
Once a shipment has been dispatched, it cannot be canceled, modified, or recalled
[DOI] [PMC free article] [PubMed] [Google Scholar] 49.Gorgojo-Martinez JJ, Mezquita-Raya P, Carretero-Gomez J, Castro A, Cebrian-Cuenca A, de Torres-Sanchez A, et al
The FDA labels for both semaglutide and tirzepatide address lactation, but the language reveals more about the state of research than the state of risk